Safety and tolerability of cidofovir in high-risk pediatric patients: Short communication

Transplant Infectious Disease

Volumn 11, Issue 4, 2009, Pages 373-379

  Bhadri, V A ^a   Lee Horn, L ^b   Shaw, P J ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Adenovirus; Cidofovir; Pediatric patients; Safety; Stem cell transplantation; Tolerability

Indexed keywords

ACICLOVIR; AMIKACIN; CIDOFOVIR; COTRIMOXAZOLE; CREATININE; CYCLOSPORIN; FOSCARNET; GANCICLOVIR; GENTAMICIN; PROBENECID; SODIUM CHLORIDE; TACROLIMUS; TEICOPLANIN; UREA; VANCOMYCIN;

ADENOVIRUS INFECTION; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG INFUSION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HIGH RISK PATIENT; HUMAN; INFANT; KIDNEY FUNCTION; MALE; NEPHROTOXICITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; UREA BLOOD LEVEL;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; CYTOSINE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; KIDNEY DISEASES; MALE; PHOSPHONIC ACIDS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 68849123242     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2009.00391.x     Document Type: Article

References (32)

1. Hierholzer J. Adenovirus in the immunocompromised host. Clin Microbiol Rev 1992 5 : 262 274.
2. Bateman C, Bleakley M, Nivison-Smith I, Shaw P. Adenovirus isolation post blood and marrow transplant (BMT) in Australia and New Zealand - results of a 4 year clinical multi-institutional prospective cohort study. Blood 2005 106 : 27a. Abstract 79.
3. Hale G, Heslop H, Krance R, et al. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 1999 23 (3) : 277 282.
4. Muller W, Levin M, Shin Y, et al. Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients. Clin Infect Dis 2005 41 : 1812 1816.
5. MIMS Australia. JuneJuly 2008 ed. CMP Medica Australia Pty Ltd, New South Wales, Australia, 2008.
6. Ljungman P, Ribaud P, Eyrich M, et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2003 31 (6) : 481 486.
7. Yusuf U, Hale G, Carr J, et al. Cidofovir for the treatment of adenoviral infection in paediatric hematopoietic stem cell transplant patients. Transplantation 2006 81 (10) : 1398 1404.
8. Common Terminology Criteria for Adverse Events v3.0 2006. Available at. Accessed 27 December 2007.
9. Leen AM, Rooney CM. Adenovirus as an emerging pathogen in immunocompromised patients. Br J Haematol 2005 128 (2) : 135 144.
10. Walls T, Shankar AG, Shingadia D. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect Dis 2003 3 (2) : 79 86.
11. Johnson PR, Yin JA, Morris DJ, Desai M, Cinkotai KI, McKeogh MM. Fulminant hepatic necrosis caused by adenovirus type 5 following bone marrow transplantation. Bone Marrow Transplant 1990 5 (5) : 345 347.
12. Liles WC, Cushing H, Holt S, et al. Severe adenoviral nephritis following bone marrow transplantation: successful treatment with intravenous ribavirin. Bone Marrow Transplant 1993 12 (4) : 409 412.
13. Bateman C, Kesson A, Shaw P. Pancreatitis and adenoviral infection in children after blood and marrow transplantation. Bone Marrow Transplant 2006 38 (12) : 807 811.
14. Murphy GF, Wood DP Jr., McRoberts JW, Henslee-Downey PJ. Adenovirus-associated hemorrhagic cystitis treated with intravenous ribavirin. J Urol 1993 149 (3) : 565 566.
15. Bordigoni P, Carret AS, Venard V, Witz F, Le Faou A. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2001 32 (9) : 1290 1297. (Pubitemid 32405900)
16. Gavin PJ, Katz BZ. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics 2002 110 (1 Part 1) : e9.
17. Ribaud P, Scieux C, Freymuth F, Morinet F, Gluckman E. Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient. Clin Infect Dis 1999 28 (3) : 690 691.
18. Legrand F, Berrebi D, Houhou N, et al. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant 2001 27 (6) : 621 626.
19. Hoffman JA, Shah AJ, Ross LA, Kapoor N. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001 7 (7) : 388 394.
20. Chakrabarti S, Mautner V, Osman H, et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 2002 100 (5) : 1619 1627.
21. Leruez-Ville M, Minard V, Lacaille F, et al. Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clin Infect Dis 2004 38 (1) : 45 52.
22. Kampmann B, Cubitt D, Walls T, et al. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol 2005 130 (4) : 595 603.
23. Hatakeyama N, Suzuki N, Kudoh T, Hori T, Mizue N, Tsutsumi H. Successful cidofovir treatment of adenovirus-associated hemorrhagic cystitis and renal dysfunction after allogenic bone marrow transplant. Pediatr Infect Dis J 2003 22 (10) : 928 929.
24. Ishida H. Invasive adenoviral infection in a recipient of unrelated bone marrow transplantation: problems with diagnostic PCR. Pediatr Blood Cancer 2005 44 : 416 419.
25. Seidermann K, Heim A, Pfister ED, et al. Monitoring of adenovirus infection in pediatric transplant recipients by quantitative PCR: report of six cases and review of the literature. Am J Transplant 2004 4 : 2102 2108.
26. Sivaprakasam P, Carr TF, Coussons M, et al. Improved outcome from invasive adenovirus infection in pediatric patients after hemopoietic stem cell transplantation using intensive clinical surveillance and early intervention. J Pediatr Hematol Oncol 2007 29 (2) : 81 85.
27. Ouachee-Chardin M, Leruez-Ville M, Rouzioux C, Blanche S. Cidofovir for adenovirus infection after allogenic hematopoietic stem cell transplantation: a single-center experience of 16 children. Blood (ASH Annual Meeting Abstracts) 2004 104 (11) : 5103.
28. Nagafuji K, Aoki K, Henzan H, et al. Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2004 34 (10) : 909 914.
29. Neofytos D, Ojha A, Mookerjee B, et al. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant 2007 13 (1) : 74 81.
30. Gorczynska E, Turkiewicz D, Rybka K, et al. Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2005 11 (10) : 797 804.
31. Robin M, Marque-Juillet S, Scieux C, et al. Disseminated adenovirus infections after allogenic hematopoietic stem cell transplantation: incidence, risk factors and outcome. Haematologica 2007 92 : 1254 1257. (Pubitemid 350144187)
32. Symeonidis N, Jakubowski A, Pierre-Louis S, et al. Invasive adenoviral infections in T-cell depleted allogenic hematopoietic stem cell transplantation: high mortality in the era of cidofovir. Transpl Infect Dis 2007 9 (2 108 113.